NCT01686958 Safety Study of MRI-guided Transurethral Ultrasound Ablation of Prostate Tissue to Treat Localized Prostate Cancer Status COMPLETED Phase NA
NCT01685983 A Study of Abiraterone Acetate (JNJ-212082) and Prednisolone in Patients With Advanced Prostate Cancer Status COMPLETED Phase PHASE2
NCT01685268 A Study of HSP90 Inhibitor AT13387 Alone or in Combination With Abiraterone Acetate Status COMPLETED Phase PHASE1/PHASE2
NCT01685190 A Study of Prostate and pelvIs Versus prOsTate Alone Treatment for Locally Advanced Prostate Cancer Status UNKNOWN Phase PHASE2
NCT01681433 OGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Receiving Abiraterone Status TERMINATED Phase PHASE2
NCT01677845 Hypo-Fractionated Radiation Therapy for Localized Prostate Cancer Status TERMINATED Phase PHASE1
NCT01676480 The Effect of Endurance Training on Body Composition and Insulin Sensitivity in Prostate Cancer Patients Receiving Androgen Deprivation Therapy Status COMPLETED Phase NA
NCT01672905 PSA Antibody Levels in Samples From Patients With Prostate Cancer Treated on Protocol ECOG-E9802 Status COMPLETED Phase N/A
NCT01672411 Predictive Value of Prostate-specific Antigen Isoform p2psa and Its Derivates in the Diagnosis of Prostate Cancer Status COMPLETED Phase N/A
NCT01667536 A Phase 2 Study With MIP-1404 in Men With High-Risk PC Scheduled for RP and EPLND Compared to Histopathology Status COMPLETED Phase PHASE2
NCT01666314 Study in Japan and Ex-Japan to Characterize the Pharmacokinetic and Pharmacodynamic Response to Orteronel (TAK-700) in Chemotherapy-Naive Participants With Castration-Resistant Prostate Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT01664923 Safety and Efficacy Study of Enzalutamide Versus Bicalutamide in Men With Prostate Cancer Status COMPLETED Phase PHASE2
NCT01660152 Vacuum Erection Device in Improving Recovery of Erectile Function in Patients With Prostate Cancer Undergoing Surgery Status COMPLETED Phase NA
NCT01656161 Study on Efficacy, Pharmacokinetics, and Safety of Two Subcutaneous Injections of Triptorelin Embonate 6 Month Formulation in Patients With Advanced Prostate Cancer Status COMPLETED Phase PHASE3
NCT01655836 High-Dose Rate Brachytherapy and Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1